Philadelphia, Pennsylvania – First Pharma (“First Pharma”), a private Australian pharmaceutical company operating in the consumer healthcare (“CHC”) segment, has successfully completed the sale of its business to a strategic buyer. First Pharma’s portfolio of products...

Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”).  The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of an out-licensing project conducted on behalf of its client, Elthera AG of Switzerland.  Plexus Ventures served as the exclusive business development advisor  to Elthera in...

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Celon Pharma. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal match which...

Philadelphia, Pennsylvania – Plexus Ventures, a prominent corporate and business development boutique for healthcare companies, is pleased to announce our newest Managing Director. The Partners at Plexus Ventures are very pleased to announce that Ahmed Al-Derzi has...

Philadelphia, Pennsylvania – First Pharma (“First Pharma”), a private Australian pharmaceutical company operating in the consumer healthcare (“CHC”) segment, has successfully completed the sale of its business to a strategic buyer. First Pharma’s portfolio of products...

Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”).  The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...